［1］李晨,甘雪琦.线粒体与骨髓间充质干细胞成骨分化关系的研究进展［J］.口腔医学研究,2023,39(01):11-14.
LI C,GAN XQ.Research advances in relationship between mitochondria and osteogenic differentiation of bone marrow mesenchymal stem cells ［J］.Journal of Oral Science Research,2023,39(01):11-14.
［2］ JIANG HW,JEDOUI M,YE JB.The Warburg effect drives dedifferentiation through epigenetic reprogramming［J］.Cancer Biology & Medicine,2024,20(12):891-897.
［3］ ROGER AJ,MUNOZ-GOMEZ SA,KAMIKAWA R.The origin and diversification of mitochondria ［J］.Current Biology,2017,27(21):R1177-R1192.
［4］ BURK D,SCHADE AL.On respiratory impairment in cancer cells［J］.Science,1956,124(3215):270-272.
［5］ SEYFRIED TN,ARISMENDI-MORILLO G,MUKHERJEE P,et al.On the origin of ATP synthesis in cancer［J］.iScience,2020,23(11):101761.
［6］ AMATO I,MEURANT S,RENARD P.The key role of mitochondria in somatic stem cell differentiation:From mitochondrial asymmetric apportioning to cell fate ［J］.International Journal of Molecular Science,2023,24(15):12181.
［7］ PROTASONI M,ZEVIANI M.Mitochondrial structure and bioenergetics in normal and disease conditions［J］.International Journal of Molecular Science,2021,22(2):586.
［8］ SINGH R,JAIN A,PALANICHAMY JK,et al.Ultrastructural changes in cristae of lymphoblasts in acute lymphoblastic leukemia parallel alterations in biogenesis markers［J］.Applied Microscopy,2021,51(1):20.
［9］ ZHENG XX,CHEN JJ,SUN YB,et al.Mitochondria in cancer stem cells:Achilles heel or hard armor［J］.Trends in Cell Biology,2023,33(8):708-727.
［10］ JOGALEKAR MP,SERRANO EE.Morphometric analysis of a triple negative breast cancer cell line in hydrogel and monolayer culture environments［J］.PeerJ,2018,6:e4340.
［11］ ARISMENDI-MORILLO G,CASTELLANO-RAMIREZ A,SEYFRIED TN.Ultrastructural characterization of the Mitochondria-associated membranes abnormalities in human astrocytomas:Functional and therapeutics implications［J］.Ultrastructural Pathology,2017,41(3):234-244.
［12］ COGLIATI S,ENRIQUEZ JA,SCORRANO L.Mitochondrial cristae:Where beauty meets functionality［J］.Trends in Biochemical Sciences,2016,41(3):261-273.
［13］ UNWIN RD,CRAVEN RA,HARNDEN P,et al.Proteomic changes in renal cancer and co-ordinate demonstration of both the glycolytic and mitochondrial aspects of the Warburg effect［J］.Proteomics,2003,3(8):1620-1632.
［14］ZHANG L,LIU MR,YAO YC,et al.Characterization and structure of glyceraldehyde-3-phosphate dehydrogenase type 1 from Escherichia coli［J］.Acta Crystallogr F Struct Biol Commun,2020,76(Pt 9):406-413.
［15］ SIMONNET H,ALAZARD N,PFEIFFER K,et al.Low mitochondrial respiratory chain content correlates with tumor aggressiveness in renal cell carcinoma［J］.Carcinogenesis,2002,23(5):759-768.
［16］ FEICHTINGER RG,WEIS S,MAYR JA,et al.Alterations of oxidative phosphorylation complexes in astrocytomas［J］.Glia,2014,62(4):514-525.
［17］ JIANG H,GREATHOUSE RL,TICHE SJ,et al.Mitochondrial uncoupling induces epigenome remodeling and promotes differentiation in neuroblastoma［J］.Cancer Research,2023,83(2):181-194.
［18］ ZHANG W,SVIRIPA VM,KRIL LM,et al.An underlying mechanism of dual Wnt inhibition and AMPK activation:Mitochondrial incouplers masquerading as Wnt inhibitors［J］.Journal of Medicinal Chemistry,2019,62(24):11348-11358.
［19］ PARADIES G,PARADIES V,DE BENEDICTIS V,et al.Functional role of cardiolipin in mitochondrial bioenergetics［J］.Biochimica et Biophysica Acta,2014,1837(4):408-417.
［20］ MUSATOV A,SEDLAK E.Role of cardiolipin in stability of integral membrane proteins［J］.Biochimie,2017,142:102-111.
［21］ LI Y,LOU W,RAJA V,et al.Cardiolipin-induced activation of pyruvate dehydrogenase links mitochondrial lipid biosynthesis to TCA cycle function［J］.The Journal of Biological Chemistry,2019,294(30):11568-11578.
［22］ JISHI M,PATEL BM.Unveiling the role of the proton gateway,uncoupling proteins(UCPs),in cancer cachexia［J］.Cancers,2023,15(5):1407.
［23］ SUN L,ZHANG H,GAO P.Metabolic reprogramming and epigenetic modifications on the path to cancer［J］.Protein & Cell,2022,13(12):877-919.
［24］ XU X,PENG Q,JIANG X,et al.Metabolic reprogramming and epigenetic modifications in cancer:from the impacts and mechanisms to the treatment potential［J］.Exp Mol Med,2023,55(7):1357-1370.
［25］ LI Y,GRUBER JJ,LITZENBURGER UM,et al.Acetate supplementation restores chromatin accessibility and promotes tumor cell differentiation under hypoxia［J］.Cell Death & Disease,2020,11(2):102.
［26］ LI AM,HE B,KARAGIANNIS D,et al.Serine starvation silences estrogen receptor signaling through histone hypoacetylation［J］.Proceedings of the National Academy of Sciences of the United States of America,2023,120(38):e2302489120.
［27］章婷婷，赵调红，陈圆圆，等.组蛋白乳酸化修饰在恶性肿瘤中的研究进展［J］.现代肿瘤医学，2024,32(06):1137-1141.
ZHANG TT,ZHAO TH,CHEN YY,et al.Advances in histone lactate modification in malignant tumors ［J］.Modern Oncology,2024,32(06):1137-1141.
［28］ JIE Y,PEIWEI C,MINYUE X,et al.Histonelactylation drives oncogenesis by facilitating m6A reader protein YTHDF2 expression in ocular melanoma［J］.Genome Biology,2021,22(1):85.
［29］ YANG J,LUO L,ZHAO C,et al.A positive feedback loop between inactive VHL-triggered histone lactylation and PDGFRβ signaling drives clear cell renal cell carcinoma progression［J］.International Journal of Biological Sciences,2022,18(8):3470-3483.
［30］ MIAO Z,ZHAO X,LIU X.Hypoxia induced β-catenin lactylation promotes the cell proliferation and stemness of colorectal cancer through the wnt signaling pathway［J］.Experimental Cell Research,2023,422(1):113439.
［31］ MCCABE MT,MOHAMMAD HP,BARBASH O,et al.Targeting histone methylation in cancer［J］.Cancer Journal(Sudbury,Mass),2017,23(5):292-301.
［32］潘云枫，王演怡，陈静雯，等.线粒体代谢介导的表观遗传改变与衰老研究［J］.遗传，2019,41(10):893-904.
PAN YF,WANG YY,CHEN JW,et al.Mitochondrial metabolism's effect on epigenetic changeand aging ［J］.Hereditas,2019,41(10):893-904.
［33］韩勖，罗凤宝，马旭怡.组蛋白甲基转移酶NSD3对肾癌细胞增殖、侵袭及迁移的影响［J］.临床与病理杂志，2023,43(12):2063-2070.
HAN X,LUO FB,MA XY.Effect of histone methyltransferase NSD3 on the proliferation,invasion,and migration of renal cancer cells ［J］.Journal of Clinical and Pathological Research,2023,43(12):2063-2070.
［34］ TOPCHU I,PANGENI RP,BYCHKOV I,et al.The role of NSD1,NSD2,and NSD3 histone methyltransferases in solid tumors［J］.Cellular and Molecular Life Sciences,2022,79(6):285.
［35］ AYTES A,GIACOBBE A,MITROFANOVA A,et al.NSD2 is a conserved driver of metastatic prostate cancer progression［J］.Nature Communications,2018,9(1):5201.
［36］ SONG D,LAN J,CHEN Y,et al.NSD2 promotes tumor angiogenesis through methylating and activating STAT3 protein［J］.Oncogene,2021,40(16):2952-2967.
［37］ TAN M,LUO H,LEE S,et al.Identification of 67 histone marks and histone lysine crotonylation as a new type of histone modification［J］.Cell,2011,146(6):1016-1028.
［38］ LI Q,HOPPE T.Role of amino acid metabolism in mitochondrial homeostasis［J］.Frontiers in Cell and Developmental Biology,2023,11:1127618.
［39］ WAN J,LIU H,CHU J,et al.Functions and mechanisms of lysine crotonylation［J］.Journal of Cellular and Molecular Medicine,2019,23(11):7163-7169.
［40］ YUAN H,WU X,WU Q,et al.Lysine catabolism reprograms tumour immunity through histone crotonylation［J］.Nature,2023,617(7962):818-826.
［41］WAN J,LIU H,MING L.Lysine crotonylation is involved in hepatocellular carcinoma progression［J］.Biomed Pharmacother,2019,111:976-982.
［42］ FELLOWS R,DENIZOT J,STELLATO C,et al.Microbiota derived short chain fatty acids promote histone crotonylation in the colon through histone deacetylases［J］.Nat Commun,2018,9(1):105.
［43］ JONES PA.Functions of DNA methylation:islands,start sites,gene bodies and beyond［J］.Nature Reviews Genetics,2012,13(7):484-492.
［44］ JONES PA,ISSA JP,BAYLIN S.Targeting the cancer epigenome for therapy［J］.Nature Reviews Genetics,2016,17(10):630-641.
［45］ HENRICH KO,BENDER S,SAADATI M,et al.Integrative genome-scale analysis identifies epigenetic mechanisms of transcriptional deregulation in unfavorable neuroblastomas［J］.Cancer Research,2016,76(18):5523-5537.
［46］ FENG J,ZHANG Y,SHE X,et al.Hypermethylated gene ANKDD1A is a candidate tumor suppressor that interacts with FIH1 and decreases HIF1α stability to inhibit cell autophagy in the glioblastoma multiforme hypoxia microenvironment［J］.Oncogene,2019,38(1):103-119.
［47］ GUO X,YANG N,JI W,et al.Mito-bomb:Targeting mitochondria for cancer therapy［J］.Adv Mater,2021,33(43):e2007778.
［48］ DE A,KUPPUSAMYG.Metformin in breast cancer:preclinical and clinical evidence［J］.Current Problems in Cancer,2020,44(1):100488.
［49］ KAMARUDIN MNA,SARKER MMR,ZHOU JR,et al.Metformin in colorectal cancer:molecular mechanism,preclinical and clinical aspects［J］.Journal of Experimental & Clinical Cancer Research,2019,38(1):491.
［50］VASAN K,WERNER M,CHANDEL NS.Mitochondrial metabolism as a target for cancer therapy［J］.Cell Metab,2020,32(3):341-352.
［51］TERAO M,GORACCI L,CELESTINI V,et al.Role of mitochondria and cardiolipins in growth inhibition of breast cancer cells by retinoic acid［J］.J Exp Clin Cancer Res,2019,38(1):436.
［52］ MCCALL CE,ZABALAWI M,LIU T,et al.Pyruvate dehydrogenase complex stimulation promotes immunometabolic homeostasis and sepsis survival ［J］.JCI Insight,2018,3(15):e99292.
［53］ CHAO Y,LIU Z.Biomaterials tools to modulate the tumour microenvironment in immunotherapy［J］.Nat Rev Bioeng,2023,1:125-138.
［54］HOLT RD.Bringing the Hutchinsonian niche into the 21st century:ecological and evolutionary perspectives［J］.Proc Natl Acad Sci USA,2009,106(Suppl 2):19659-19665.
［55］LI Z,SUN C,QIN Z.Metabolic reprogramming of cancer-associated fibroblasts and its effect on cancer cell reprogramming［J］.Theranostics,2021,11(17):8322-8336.
［56］ BANTUG GR,HESS C.The immunometabolic ecosystem in cancer［J］.Nat Immunol,2023,24(12):2008-2020.
［57］ HUO M,ZHANG J,HUANG W,et al.Interplay among metabolism,epigenetic modifications,and gene expression in cancer［J］.Frontiers in Cell and Developmental Biology,2021,9:793428.
［58］SAINERO-ALCOLADO L,LIANO-PONS J,RUIZ-PEREZ MV,et al.Targeting mitochondrial metabolism for precision medicine in cancer［J］.Cell Death Differ,2022,29(7):1304-1317.
［59］ PENG H,YAO F,ZHAO J,et al.Unraveling mitochondria-targeting reactive oxygen species modulation and their implementations in cancer therapy by nanomaterials［J］.Exploration(Beijing),2023,3(2):20220115.